Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Emergency Use Authorization for Gene-RADAR® Zika Virus Test: FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform

Abstract:
Nanobiosym Diagnostics Inc. (Nanobiosym) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Gene-RADAR® Zika Virus Test.

Emergency Use Authorization for Gene-RADAR® Zika Virus Test: FDA Authorization for the Gene-RADAR® Zika Virus Test on the XPRIZE-Winning Gene-RADAR® Platform

Cambridge, MA | Posted on April 14th, 2017

Nanobiosym Diagnostics Inc. (Nanobiosym) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Gene-RADAR® Zika Virus Test.

Dr. Anita Goel, M.D., Ph.D., demonstrates the highly portable Gene-RADAR device to NASA scientists.

"This FDA EUA represents a major milestone towards realizing our deeper vision: to decentralize, personalize, and mobilize the next generation of healthcare, much like cell phones transformed the telecommunications industry," said Dr. Anita Goel, M.D., Ph.D., Chairman and CEO of Nanobiosym and a Harvard-MIT trained physicist and physician. "The FDA's prompt feedback has accelerated our journey from winning the first XPRIZE for healthcare to bringing this new technology to patients and providers battling Zika on the front lines."

According to the Centers for Disease Control (CDC), more than 43,000 people in the U.S. and its territories have already been infected by the Zika virus, including at least 4,750 pregnant women. One of the greatest threats of Zika infection occurs during pregnancy, potentially resulting in significant neurological problems in the developing baby, such as severe microcephaly, decreased brain tissue and brain damage.

Currently, Zika virus RNA has been detected in serum up to 13 days post-symptom onset in non-pregnant patients, up to 62 days post-symptom onset in pregnant patients and up to 53 days after the last known possible exposure in an asymptomatic pregnant woman. In addition, recent studies have demonstrated Zika virus RNA detection in semen and whole blood 34 days1 and two months2 post-infection, respectively. The Gene-RADAR® Zika Virus Test should be performed according to CDC's algorithm for Zika testing (see http://www.cdc.gov/zika/laboratories/lab-guidance.html).

"Access to this important new testing technology represents an important breakthrough in 'real-time' Zika testing, and partnering with Nanobiosym allows us to bring cutting-edge Gene-RADAR® testing to our patients here in Florida," said Dr. D.T. Jayaweera, M.D., Executive Dean for Infectious Disease Research at the Miller School of Medicine at the University of Miami, which has signed a Memorandum of Understanding with Nanobiosym to evaluate the real-world clinical and operational utility of the Gene-RADAR® platform. "Mitigating the further spread of Zika virus infection in Florida and effectively managing the spectrum of neurological problems in newborn babies and adults is a top priority for us."


1 Driggers, R.W., et al. Zika virus infection with Prolonged Maternal Viremia and Fetal
Brain Abnormalities. New England Journal of Medicine, June 2, 2016; 374:2142-2151.
DOI: 10.1056/NEJMoa1601824

2 Meaney-Delman et al. Prolonged Detection of Zika Virus RNA in Pregnant Women.
Obstetrics and Gynecology, 128:724-730. DOI: 10.1097/AOG.0000000000001625

####

About Nanobiosym Diagnostics Inc.
Nanobiosym Diagnostics aims to bring the XPRIZE-winning Gene-RADAR® platform technology to over four billion people on the planet that currently lack access to basic healthcare. In addition to the Gene-RADAR® Zika Virus Test that has been granted an Emergency Use Authorization by the FDA, the Company is developing expanded clinical sample input options to include other body fluids such as whole blood and urine. Currently, the Gene-RADAR® Zika Virus Test has only been authorized for the detection of RNA from Zika virus in human serum, not for any other body fluids or any other viruses or pathogens.

The Nanobiosym Research Institute focuses on creating breakthrough scientific insights and developing transformational technologies that emerge from the convergence of physics, nanotechnology, and biomedicine. Nanobiosym has been awarded several prestigious peer-reviewed awards and grants from U.S. federal agencies, including DARPA, NSF, DOD, DOE, CASIS (in affiliation with NASA), and USAID. Nanobiosym, under Dr. Goel's leadership, is harnessing the science of nanobiophysics to develop and clinically validate a pipeline of novel "apps" for the Gene-RADAR® Platform as well as enhance the mobility and other performance metrics of the underlying platform.

For more information, visit www.nanobiosym.com or follow @Nanobiosym on Twitter.

For more information, please click here

Copyright © Nanobiosym Diagnostics Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Full Nanobiosym Gene-RADAR® Zika Virus Test EUA at:

Further details about the Zika Virus in the U.S. and worldwide at:

Related News Press

News and information

Affordable STM32 Cloud-Connectable Kit from STMicroelectronics Puts More Features On-Board for Fast and Flexible IoT-Device Development April 26th, 2017

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

Using light to propel water : With new method, MIT engineers can control and separate fluids on a surface using only visible light April 25th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Govt.-Legislation/Regulation/Funding/Policy

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Better living through pressure: Functional nanomaterials made easy April 19th, 2017

Possible Futures

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Russian scientists create new system of concrete building structures: Sientists of Peter the Great Saint-Petersburg Polytechnic University developed a new construction technology April 24th, 2017

Nanomedicine

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

Nanotubes that build themselves April 14th, 2017

Announcements

Affordable STM32 Cloud-Connectable Kit from STMicroelectronics Puts More Features On-Board for Fast and Flexible IoT-Device Development April 26th, 2017

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

Using light to propel water : With new method, MIT engineers can control and separate fluids on a surface using only visible light April 25th, 2017

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Using light to propel water : With new method, MIT engineers can control and separate fluids on a surface using only visible light April 25th, 2017

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Russian scientists create new system of concrete building structures: Sientists of Peter the Great Saint-Petersburg Polytechnic University developed a new construction technology April 24th, 2017

Nanobiotechnology

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

Nanotubes that build themselves April 14th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project